Full text

Turn on search term navigation

© 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The highly heterogeneous characteristics of Wharton's jelly mesenchymal stem cells (WJ-MSCs) may be responsible for the poor clinical outcomes and poor reproducibility of treatments based on WJ-MSCs. Exploration of WJ-MSC heterogeneity with multimodal single-cell technologies will aid in establishing accurate MSC subtyping and developing screening protocols for dominant functional subpopulations. Here, the characteristics of WJ-MSCs are systematically analyzed by single cell and spatial transcriptome sequencing. Single-cell transcriptomics analysis identifies four WJ-MSC subpopulations, namely proliferative_MSCs, niche-supporting_MSCs, metabolism-related_MSCs and biofunctional-type_MSCs. Furthermore, the transcriptome, cellular heterogeneity, and cell-state trajectories of these subpopulations are characterized. Intriguingly, the biofunctional-type MSCs (marked by S100A9, CD29, and CD142) selected in this study exhibit promising wound repair properties in vitro and in vivo. Finally, by integrating omics data, it has been found that the S100A9+CD29+CD142+ subpopulation is more enriched in the fetal segment of the umbilical cord, suggesting that this subpopulation deriving from the fetal segment may have potential for developing into an ideal therapeutic agent for wound healing. Overall, the presented study comprehensively maps the heterogeneity of WJ-MSCs and provides an essential resource for future development of WJ-MSC-based drugs.

Details

Title
Single-Cell and Spatial Transcriptomics Decodes Wharton's Jelly-Derived Mesenchymal Stem Cells Heterogeneity and a Subpopulation with Wound Repair Signatures
Author
Chen, Penghong 1   VIAFID ORCID Logo  ; Tang, Shijie 1   VIAFID ORCID Logo  ; Li, Ming 1 ; Wang, Dezhi 1 ; Chen, Caixiang 1 ; Qiu, Yiqun 1 ; Fang, Zhuoqun 1 ; Zhang, Haoruo 1 ; Gao, Hangqi 1 ; Weng, Haiyan 1 ; Hu, Kailun 1 ; Lin, Jian 1 ; Lin, Qingxia 2 ; Tan, Yi 3 ; Li, Shirong 4 ; Chen, Jinghua 5   VIAFID ORCID Logo  ; Chen, Liangwan 6   VIAFID ORCID Logo  ; Chen, Xiaosong 1   VIAFID ORCID Logo 

 Department of Plastic Surgery and Regenerative Medicine, Fujian Medical University Union Hospital, Fuzhou, China; Department of Plastic Surgery and Regenerative Medicine Institute, Fujian Medical University, Fuzhou, China; Engineering Research Center of Tissue and Organ Regeneration, Fujian Province University, Fuzhou, China; Department of Stem Cell Research Institute, Fujian Medical University, Fuzhou, China 
 Department of Obstetrics, Quanzhou Women and Children's Hospital, Quanzhou, China 
 Qilu Cell Therapy Technology Co., Ltd, Jinan, Shandong, China 
 Department of Plastic and Reconstructive Surgery, Shinrong Plastic Surgery Hospital, Chongqing, China 
 Department of Pharmaceutical Analysis, the School of Pharmacy, Fujian Medical University, Fuzhou, China 
 Engineering Research Center of Tissue and Organ Regeneration, Fujian Province University, Fuzhou, China; Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China 
Section
Research Articles
Publication year
2023
Publication date
Feb 2023
Publisher
John Wiley & Sons, Inc.
e-ISSN
21983844
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2771851734
Copyright
© 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.